
Sotera Health rose 1.2% from $16.25 to $16.44, behind the S&P 500's +11.2%. Its worst day was Nov 3 (−9.6%), and its low came Mar 27 at $13.13.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.26 beat the $0.23 estimate on $303.4M revenue (est. $300.1M); FY revenue guidance of $1.2B–$1.3B against the $1.2B consensus.
−4.4% · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
Sotera Health closed at its lowest level of the year, 19.2% below where the year started.
−3.0% · S&P 500 −1.7%
EPS of $0.18 beat the $0.17 estimate on $280.0M revenue (est. $271.0M); FY revenue guidance of $1.2B–$1.3B against the $1.2B consensus.
−0.4% · S&P 500 +0.8%
Sotera Health shares rose 5.4%, while the S&P 500 fell 0.0%.
+5.4% · S&P 500 0.0%
Sotera Health shares rose 5.3%, while the S&P 500 rose 0.8%.
+5.3% · S&P 500 +0.8%
EPS of $0.26 beat the $0.24 estimate on $321.4M revenue (est. $309.9M); FY revenue guidance of $1.2B–$1.3B against the $1.2B consensus.
+5.2% · S&P 500 −0.2%
Sotera Health closed at its highest level of the year, 20.4% above where the year started.
+1.8% · S&P 500 +0.4%
EPS of $0.29 beat the $0.26 estimate on $324.9M revenue (est. $319.8M); FY revenue guidance of $1.2B–$1.3B against the $1.2B consensus.
−9.6%, the year's worst day · S&P 500 +0.3%
Where it ended: a close of $16.44 on Nov 11, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $0.26, revenue est. $317.8M).
Nothing in the past 12 months.
All SHC dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SHC and SPY from Benzinga historical bars. Not investment advice.